Transferrin participates in the pathogenesis of endometriosis by influencing the proliferation, migration and apoptosis of endometrial cells

This study demonstrates that transferrin (TF) is upregulated in endometriosis and contributes to the disease's pathogenesis by promoting the proliferation and migration of endometrial stromal cells while inhibiting their apoptosis, likely through the modulation of ferroptosis-related pathways.

The Gist

🩺 The Big Picture: What is Endometriosis?

Imagine your uterus is a garden that is supposed to be cleaned out every month (your period). In Endometriosis, some of that garden soil (endometrial tissue) escapes and gets planted in the wrong places, like the ovaries or the pelvic wall.

Normally, your body would clean up this "weeds." But in endometriosis, these weeds are stubborn. They grow back faster, spread like crazy, and refuse to die. This causes pain, scarring, and infertility. Scientists have been trying to figure out why these weeds are so tough.

🔍 The New Clue: Iron and the "Rusty" Problem

This study focuses on a specific ingredient: Iron.

When endometriosis tissue bleeds inside the body, it releases a lot of iron. Think of iron like rust.

• The Problem: Too much iron inside a cell is like having a rusty machine. It creates "rusty sparks" (called ROS or free radicals) that damage the cell from the inside.
• The Defense: Healthy cells have a "fire extinguisher" system to put out these rusty sparks. The main part of this system is a molecule called GSH (Glutathione) and a protein called GPX4.
• The Twist: The researchers found that in endometriosis patients, the "fire extinguisher" (GSH) is broken or missing. This means the cells are sitting in a pool of rusty sparks, which should normally kill them.

🚚 The Star of the Show: Transferrin (TF)

So, if the cells are surrounded by rusty sparks, why aren't they dying? That's where Transferrin (TF) comes in.

Think of Transferrin as a delivery truck.

• Its job is to pick up iron from the blood and deliver it to cells.
• In a healthy body, this is a normal, helpful delivery.
• In Endometriosis: The researchers found that the "delivery trucks" (Transferrin) are overdrive. They are delivering way too much iron to the endometriosis cells.

🧪 What Did the Scientists Do?

The team took cells from three groups:

1. Normal women (The Control Group).
2. Women with endometriosis (The "Eutopic" group - tissue from inside the uterus).
3. Women with endometriosis (The "Ectopic" group - the actual painful lesions outside the uterus).

What they found:

• The "weed" cells (endometriosis) were growing and moving much faster than normal cells.
• The "fire extinguisher" (GSH) was low in the weed cells.
• The "delivery trucks" (Transferrin) were supercharged in the ectopic lesions.

🛑 The Experiment: Turning Off the Trucks

To prove that the delivery trucks were the problem, the scientists used a special tool (siRNA) to turn off the Transferrin trucks in the lab-grown endometriosis cells.

The Result?
When they stopped the iron deliveries:

1. The weeds stopped growing: The cells stopped multiplying.
2. The weeds stopped moving: They couldn't spread to new areas.
3. The weeds died: The cells finally let go and died (apoptosis).

💡 The Takeaway

This study suggests a new way to think about endometriosis:
The disease survives because it is hijacking the iron delivery system. It uses too many "Transferrin trucks" to bring in iron, which actually helps the cells grow and ignore the body's natural death signals.

The "Aha!" Moment:
If we can find a way to block the Transferrin trucks (or tell them to stop delivering iron), we might be able to starve the endometriosis cells, stop them from spreading, and make them die naturally. This could lead to new, better treatments for women suffering from this painful condition.

📝 Summary in One Sentence

Endometriosis cells are like stubborn weeds that survive by stealing too much iron via "delivery trucks" called Transferrin; if we block these trucks, the weeds stop growing and die.

Technical Summary

Title

Transferrin participates in the pathogenesis of endometriosis by influencing the proliferation, migration, and apoptosis of endometrial cells.

1. Problem Statement

Endometriosis (EM) is a prevalent gynecological disorder characterized by the growth of endometrial-like tissue outside the uterine cavity, leading to pain, infertility, and lesion recurrence. Despite its benign histology, EM exhibits malignant-like behaviors such as invasion, metastasis, and recurrence. The precise pathogenesis remains incompletely understood, though iron overload and oxidative stress are suspected contributors.

• The Iron-Ferroptosis Link: Retrograde menstruation and hemorrhage in ectopic lesions lead to iron accumulation. This free iron catalyzes the Fenton reaction, generating reactive oxygen species (ROS) and lipid peroxidation, potentially triggering ferroptosis (an iron-dependent form of regulated cell death).
• The Knowledge Gap: While ferroptosis is known to be involved in EM, the specific role of Transferrin (TF)—the primary iron carrier protein—in regulating the survival, proliferation, and migration of endometrial stromal cells within this context is unclear.

2. Methodology

The study employed a combination of clinical sample analysis, in vitro cell culture, molecular biology, and functional assays.

• Clinical Cohort:

  • Participants: 43 women enrolled from Shaoxing Maternity and Child Health Care Hospital (Jan 2022 – Sept 2024).
  • Groups:
    • Ctrl: Normal eutopic endometrium from non-EM patients.
    • EuE: Eutopic endometrium from EM patients.
    • EcO: Ectopic ovarian lesions from EM patients (ASRM Stage II-IV).
  • Exclusion Criteria: No history of immune disorders, acute inflammation, estrogen-dependent diseases, or recent hormonal medication use.

• Cell Culture:

  • Primary endometrial stromal cells (ESCs) were isolated via collagenase type IV digestion and cultured in DMEM/F12 with 10% FBS. Passage 3 cells were used for experiments.

• Molecular & Biochemical Assays:

  • Western Blotting: Analyzed protein expression of Transferrin (TF), Transferrin Receptor (TFRC), and Glutathione Peroxidase 4 (GPX4).
  • Glutathione (GSH) Assay: Quantified intracellular GSH levels to assess antioxidant capacity.
  • Knockdown Strategy: Lentiviral-mediated siRNA was used to knock down TF expression in ESCs. Efficiency was confirmed via qRT-PCR and Western blot.

• Functional Assays:

  • Proliferation: CCK-8 assay and clonogenic assays.
  • Migration: Wound healing assay (scratching monolayers and measuring closure over 0–48 hours).
  • Apoptosis: Flow cytometry using Annexin V-FITC/PI staining to detect early and late apoptosis.

• Statistical Analysis: Data analyzed using GraphPad Prism (v6.02) via Student's t-test or one-way ANOVA ($P < 0.05$ considered significant).

3. Key Contributions

• Elucidation of TF Role: First study to specifically link Transferrin dysregulation to the aberrant biological behaviors (proliferation, migration, apoptosis resistance) of endometrial cells in EM.
• Mechanistic Insight: Connects iron metabolism (via TF/TFRC) to the ferroptosis pathway (via GPX4/GSH depletion) in the context of endometriosis progression.
• Therapeutic Target Identification: Validates TF knockdown as a potential strategy to suppress EM progression by restoring apoptotic sensitivity and inhibiting cell migration.

4. Key Results

• Enhanced Malignant Phenotype:
  • ESCs from both EuE and EcO groups exhibited significantly enhanced proliferation and migration compared to normal controls (Ctrl).
• Ferroptosis Markers in EM:
  • GSH Depletion: Intracellular GSH levels were drastically reduced in both EuE (97.18% reduction) and EcO (71.13% reduction) tissues compared to Ctrl, indicating compromised antioxidant defense.
  • Protein Expression:
    • TF: Significantly upregulated in ectopic lesions (EcO).
    • TFRC: Significantly upregulated in eutopic lesions (EuE).
    • GPX4: Significantly downregulated in ectopic lesions (EcO), suggesting a failure to inhibit lipid peroxidation.
• Functional Impact of TF Knockdown:
  • Proliferation: Silencing TF significantly suppressed cell proliferation (CCK-8 and colony formation).
  • Migration: TF knockdown significantly reduced wound closure rates and the number of migrated cells.
  • Apoptosis: Knockdown of TF significantly increased the apoptosis rate in endometrial stromal cells, reversing the apoptosis resistance typically seen in EM.

5. Significance and Conclusion

• Pathogenic Mechanism: The study proposes a model where iron accumulation in EM lesions leads to upregulated TF and TFRC expression. This increases intracellular labile iron, driving ROS production and lipid peroxidation. Paradoxically, while ferroptosis is a cell death mechanism, the study suggests that the dysregulation of these pathways (specifically the upregulation of TF and downregulation of GPX4) creates a microenvironment that favors the survival and aggressive behavior of ectopic cells, possibly by selecting for cells that can withstand oxidative stress or by utilizing ROS for signaling.
• Clinical Implications: The findings identify Transferrin as a critical driver of endometriosis progression. Targeting TF could potentially inhibit the proliferation and migration of ectopic lesions while promoting their apoptosis.
• Future Directions: The authors conclude that while TF is a promising therapeutic target, further validation in animal models and clinical trials is necessary to confirm its efficacy in treating endometriosis.

Limitations Noted: The study is primarily in vitro and based on human tissue samples; in vivo animal models are required to fully validate the therapeutic potential of TF inhibition.